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Abstract
Background The purpose of the present study was to
challenge the hypothetical advantage of single port lapa-
roscopy (SPL) over conventional laparoscopy by measur-
ing prospectively the morbidity specifically related to
conventional trocar sites (TS).
Methods From November 2010 to December 2011, 300
patients undergoing various laparoscopic procedures were
enrolled. Patient, surgery, and trocar characteristics were
recorded. We evaluated at three time points (in-hospital
and at 1 and 6 months postoperatively) specifically for
each TS, pain (Visual Analog Scale), morbidity (infection,
hematoma, hernia), and cosmesis (Patient Scar Assessment
Score; PSAS). Patients designated their ‘‘worst TS,’’ and a
composite endpoint ‘‘bad TS’’ was defined to include any
adverse outcome at a TS.
Results We analyzed 1,074 TS. Follow-up was [90 %.
Pain scores of [3/10 at 1 and 6 months postoperatively,
were reported by 3 and 1 % of patients at the 5 mm TS and
by 9 and 1 % at the larger TS, respectively (5 mm TS vs
larger TS; p = 0.001). Pain was significantly lower for TS
located in the lower abdomen than for the upper abdomen
or the umbilicus (p = 0.001). The overall complication
rate was \1 % and significantly lower for the 5 mm TS
(hematoma p = 0.046; infection p = 0.0001). No hernia
was found. The overall PSAS score was low and signifi-
cantly lower for the 5 mm TS (p = 0.0001). Significant
predictors of ‘‘bad TS’’ were larger TS (p = 0.001),
umbilical position (p = 0.0001), emergency surgery
(p = 0.0001), accidental trocar exit (p = 0.022), fascia
closure (p = 0.006), and specimen extraction site
(p = 0.0001).
Conclusions Specific trocar morbidity is low and almost
negligible for 5 mm trocars. The umbilicus appears to be
an unfavorable TS.
Introduction
Laparoscopy has become the gold standard for a growing
number of abdominal surgical procedures despite very few
adequately powered prospective randomized studies. The
further evolution of minimally invasive surgery includes
single port laparoscopy (SPL) and natural orifice translu-
minal endoscopic surgery (NOTES).
The declared purposes of these even less invasive or
‘‘scarless’’ techniques is to further decrease morbidity and
improve cosmetic results by reducing the number of inci-
sions to a single surgical access or accessing the abdomen
through natural orifices. Feasibility has been reported in
several studies, but significant proof of benefit is still
awaited. A few randomized controlled trials comparing
SPL with multiport laparoscopy for various surgical pro-
cedures have been performed, showing longer operating
times with a rate of conversion to multiport laparoscopy up
to 51 %, and no difference in morbidity [1–6]. The cos-
metic outcome, despite being frequently used as major
argument to promote SPL, has been assessed only by few
authors but without use of validated instruments [7, 8]. In
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many laparoscopic procedures, a mini-laparotomy is nec-
essary to allow extraction of the surgical specimen. With
SPL, all trocars are inserted through a port that is also used
for specimen extraction. Therefore, the difference in
‘‘invasiveness’’ between multiport laparoscopy and SPL, at
least in these cases, can only be derived from a decrease in
morbidity specifically related to the additional trocars used
in multiport laparoscopy. However, an exact quantitative
analysis of the morbidity specifically related to TS is hardly
available in the literature. There are some data on TS
complications, such as infection and hernia [4–6], but they
are mostly derived from retrospective studies without
specific focus on the TS. The present study was therefore
designed to assess prospectively all adverse outcomes
specifically related to TS. It was also hypothesized that
outcomes related to 5 mm trocar sites (5TS) are more
favorable compared to larger trocar sites (LTS) and aimed
at identifying other predictors of adverse outcome at the
trocar site.
Methods
Patients and data acquisition
The present prospective observational study was performed
in our tertiary care institution. It included all patients
undergoing laparoscopic surgery with at least one 5 mm
trocar. Patients undergoing pure SPL were not included.
We also excluded patients if laparoscopy had to be con-
verted to open surgery (unplanned necessity to perform a
laparotomy longer than that needed for specimen extrac-
tion), if they were younger than 18 years or had language
limitations, or if follow-up was impossible (patients oper-
ated on emergently in our department but living abroad).
As this study was observational and did not involve any
modification in the routine procedure, patients were asked
to participate and signed an informed consent, usually on
the day after surgery. Then, the investigators, together with
the operating surgeon, filled out a detailed standardized
data sheet (Appendix 1). Size, type, and precise trocar
localization were recorded, together with patients’ baseline
characteristics, type and duration of surgery, and method of
wound closure. Trocar sites replaced by a minilaparotomy
for specimen extraction or a stoma were excluded from the
analysis, as the present study focuse on trocars only.
Location of TS was categorized as umbilical (in or around
the umbilicus), upper abdominal (at or above the umbilical
level), or lower abdominal. Trocars were categorized by
size to 5 mm or LTS, including 10, 12, and 15 mm. Single
port access trocars were excluded from the study. The
exact length of trocar incisions wasn’t measured, because it
was assumed that the operating surgeon tailored the
incision according to the size of trocar used. The rela-
tionship between the trocar and length of incision was
checked during follow-up.
Patient outcomes were assessed at three time points:
shortly prior to discharge from the hospital but within
1 week of surgery (in-hospital assessment), at 1 month
postoperatively, and at 6 months after surgery. In-hospital
assessment was based on clinical examination in all
patients. Evaluation of outcomes at 1 and 6 months was
performed during outpatient visits, but patients who were
unable or unwilling to attend were evaluated by a struc-
tured telephone interview. A study investigator (surgical
resident or study nurse) assessed or asked the patient to
report on the following outcomes, specifically for each
trocar site: pain, surgical site infection (SSI), hematoma,
hernia, cosmetic outcome, ‘‘worst TS,’’ and ‘‘overall nui-
sance,’’ based on a standardized questionnaire.
Pain was evaluated with the visual analogue scale
(VAS) [9] at rest and with effort before discharge, and
overall at 1 and 6 months. Surgical site infection was
defined according to the Centers for Disease Control and
Prevention criteria [10]. Hematoma was defined as bruising
visible or palpable on an area more than 3 cm around the
trocar site. Both were assessed prior to discharge and at
1 month. Hernia was assessed by clinical examination or
by questioning for specific symptoms at 1 and 6 months.
The cosmetic result was evaluated at 1 and 6 months with
the validated ‘‘Patient Scar Assessment Score’’ (PSAS)
[11], where the best possible score is 0 and the worst 60
(Appendix 2). We also asked patients at the three time
points to indicate subjectively which trocar site they would
have liked to avoid if the same surgery could have been
performed with one trocar less (‘‘worst TS’’), and to rate all
trocars on the VAS for ‘‘overall nuisance’’ (including pain,
complications, or adverse cosmetic outcomes). Finally, we
defined a composite endpoint ‘‘bad TS’’ as any trocar that
fulfilled one or more of the following conditions: pain or
overall nuisance rated with a VAS above 3/10 at follow-up,
elected as ‘‘worst TS,’’ rated with a PSAS score above 6/60
or subject to a complication (SSI, hematoma, or hernia).
Postoperative analgesia was not standardized but usually
included paracetamol, metamizole, and opioids, according
to hospital guidelines and based on surgery type and
patient. Local anesthesia infiltration of trocar sites was not
used.
Statistical analysis
Logistic regression analysis was performed to analyze the
binary outcomes: SSI, hematoma, ‘‘worst TS,’’ and ‘‘bad
TS.’’ To take into account the intragroup correlation (the
observations are independent across groups/patients, but
not necessarily within groups), the clustered sandwich
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estimator was used to estimate the variance–covariance
matrix (vce).
For the outcomes, VAS (t = 0,1,6), PSAS (t = 1,6), and
overall nuisance (t = 1,6). The analysis was performed by
the generalized linear latent and mixed models
GLLAMMS using the binomial family and ordinal logistic
link. The VAS was arbitrarily divided into three categories
(1 = 0, 2 = 1–3, 3 = 4–10). The PSAS was arbitrarily
divided into four categories (1 = 0, 2 = 1–6, 3 = 7–20,
4 = 21–60). A univariate analysis was performed for each
outcome. Significant predictors at level 5 % were used in a
backward procedure to fit a multivariate model. As this was
an observational study, we did not perform any sample size
calculations but arbitrarily set the sample size at 300,
expecting to reach an approximate number of 1,000 trocars.
The study was approved by the institutional ethics
committee.
Results
Patients and surgery
Between 1 November 2010 and 31 December 2011, 690
consecutive patients were operated by laparoscopy in our
institution. Three-hundred ninety patients were excluded
(266 were not asked to participate in absence of investi-
gators; 36 were operated by SPL; 3 without at least one
5 mm trocar; in 13 follow-up would have been impossible
because they resided abroad; 30 had language problems; 25
refused to give written consent; 7 had unplanned open
surgery; 1 patient died during surgery). Finally 300 patients
were included, 154 (51 %) were operated electively and
146 (49 %) underwent an emergency procedure. Table 1
shows the type of procedures performed. There were 1,074
trocar sites on the 300 patients; 477 (44 %) were 5 mm TS,
and 597 (56 %) were larger TS (LTS): 301 were 10 mm
trocars, 256 were 12 mm trocars, and 40 were 15 mm
trocars. All trocars were of the blunt tip type. Thirty-eight
procedures were converted to minilaparotomy, and 9
required a stoma; these 47 operations were therefore
excluded from the final analysis. Fascia closure was per-
formed in 71 % of LTS and 3 % of 5 mm TS. The LTS in
which the fascia was left open were mostly located below
the xiphoid. In 60 % of our patients, the resection specimen
(appendix, gallbladder) was extracted through the umbili-
cus, and all umbilical trocars were LTS.
Follow-up
Patient follow-up was complete for all patients at the in-
hospital assessment, 90 % at 1 month (87 % clinical
assessment, 13 % telephone interview), and 91 % at
6 months (59 % clinical assessment, 41 % telephone
interview).
Complications
Complications related to the trocar sites are shown in
Table 2. They were significantly less frequent in 5 mm TS
compared to LTS. No trocar site hernia was found at the
6-month follow-up.
Table 1 Laparoscopic
procedures: patient and trocar
distribution
5 mm TS 5 millimter trocar site;
LTS larger trocar site
Patients Number
of trocars
5 mm TS LTS
Total 300 1,074 477 (44 %) 598 (56 %)
Emergency 146 (49 %)
Elective 154 (51 %)
n/477 n/598
Cholecystectomy 94 286 (27 %) 109 (23 %) 177 (30 %)
Appendectomy 80 247 (23 %) 99 (21 %) 148 (23 %)
Colon resection 26 90 (8 %) 47 (10 %) 43 (7 %)
Rectal resection 12 44 (4 %) 21 (4 %) 23 (4 %)
Rectopexy 2 8 (0.7 %) 4 (0.8 %) 4 (0.6 %)
Gastric by-pass (or other bariatric procedure) 42 241 (22 %) 115 (24 %) 126 (21 %)
Nephrectomy (hand-assisted) 6 17 (2 %) 6 (1 %) 11 (2 %)
Surrenalectomy 3 11 (1 %) 2 (0.4 %) 9 (1 %)
Splenopancreatectomy 1 3 (0.3 %) 2 (0.4 %) 1 (0.1 %)
Nissen fundoplication 6 30 (3 %) 18 (4 %) 12 (2 %)
Explorative laparoscopy (adhesiolysis,
perforated ulcer suture, etc.)
26 87 (8 %) 49 (10 %) 38 (6 %)
Other 2 7 (0.6 %) 4 (0.8 %) 3 (0.5 %)
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Pain
Pain at the TS was minimal for the majority of patients
(Fig. 1). There were significant differences between 5 mm
TS and LTS (OR = 0.56, p = 0.0001, confidence interval
[CI] 95 % 0.47–0.67). At 1 month, patients reported pain
of 3/10 or less on the VAS scale in 97 % for 5 mmTS
versus 91 % for LTS, whereas at 6 months they reported
pain of 3/10 or less in 99 % of cases for both types of trocar
site. Trocars placed in the lower abdomen caused signifi-
cantly less pain (OR = 0.57, p = 0.001, CI 95 %
0.41–0.80).
‘‘Overall nuisance’’
Similarly, ‘‘overall nuisance’’ was rated 3/10 or less on the
VAS scale in 95 % for 5 mm TS versus 88 % for LTS.
There were significant differences between 5 mm TS and
LTS (OR 0.53, p = 0.0001, 95 % CI 0.39–0.73) (Fig. 2).
Cosmetic outcome
The cosmetic outcome as evaluated by the patient on the
PSAS for each 5 mm TS was 6/60 or less in 60 % of
patients at 1 month versus 41 % for LTS. At 6 months, this
proportion of patients increased to 80 % for 5 mm TS
versus 72 % for LTS (Fig. 3). Patients were therefore
significantly more satisfied with 5 mm TS scars than LTS
scars (OR 0.57, p = 0.0001, CI 95 % 0.48–0.67).
‘‘Worst trocar’’
Five patients were unable to indicate a ‘‘worst TS,’’ and 31
considered a TS converted to a minilaparotomy or stoma as
‘‘worst TS’’; these patients were excluded from analysis. In
the remaining patients, the ‘‘worst TS’’ was a LTS in 76 %
and a 5 mm TS in 24 % (198 and 64 operations, respec-
tively); 25 of these 5 mm TS had been used to exteriorize a
drain. The difference between 5 mm TS and LTS was
found to be statistically significant at univariate and mul-
tivariate analysis at the in-hospital assessment and at both
1 month and 6 months follow-up (p = 0.0001). The
‘‘worst TS’’ was most frequently located at the umbilicus
(50 %), followed by the upper abdomen (31 %) and lower
Fig. 1 Trocar site pain assessment. The Visual Analog Scale (VAS)
score according to three main categories (0/1–3/4–10) at the in-
hospital assessment (at rest and with effort), at 1 month, and at
6 months for 5 mm TS 5 mm trocar sites; LTS larger trocar sites (10,
12, and 15 mm)
Fig. 2 Trocar site ‘‘overall nuisance’’ assessment (VAS). 5 mm TS
vs LTS at 1 and 6 months postoperatively
Table 2 Trocar site morbidity
5 mm TS LTS p Value
Hematoma 8 (0.01 %) 71 (6.6 %) 0.0001
SSI 1 (0.001 %) 10 (1 %) 0.046
Hernia 0 0
Fig. 3 Trocar site Patient Scar Assessment Score (PSAS). The PSAS
was divided (arbitrarily) into four categories (0: no esthetical
discomfort; 1 \ 6: little discomfort; 7 \ 20: mild discomfort;
21 \ 60: big discomfort) for 5 mm TS versus LTS at 1 and 6 months
evaluation
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abdomen (19 %). This difference was statistically signifi-
cant at the in-hospital assessment (OR = 3.04,
p = 0.0001, 95 % CI 1.97–4.66), and still significant at
1 month and 6 months follow-up (OR = 1.77, p = 0.004,
95 % CI 1.19–2.62). Multivariate analysis confirmed that
the umbilical location predicted a ‘‘worst TS’’ outcome,
independent of size, fascia closure, and specimen extrac-
tion site (Table 3).
Composite endpoint ‘‘bad TS’’
Three hundred seventy-one LTS (73 %) matched our def-
inition of ‘‘adverse outcome’’ versus 133 5 mm TS (27 %).
We found that LTS, emergency surgery, intraumbilical
localization, intraoperative accidental exit and reinsertion
of trocars, specimen extraction site, and fascia closure were
significant predictors of adverse outcome in univariate and
multivariate analysis (Table 4).
Patient factors
Regarding patient-related factors (BMI, diabetes, oral anti-
coagulation, immunosuppression, tobacco use) we found a
Table 3 Significant factors marking adverse outcomes for pain, ‘‘worst TS,’’ overall nuisance, and PSAS
Outcomes Univariate analysis Multivariate analysis
Factors OR p (\0.05) CI 95 % Factors OR p (\0.05) IC 95 %
Pain (VAS) BMI 0.96 0.0001 0.94–0.99 5 mm TS 0.54 0.0001 0.43–0.67
5 mm TS 0.56 0.0001 0.47–0.67 BMI 0.96 0.001 0.94–0.99
Infra-umbilical location 0.73 0.018 0.57–0.94 Infra-umbilical location 0.57 0001 0.41–0.80
Emergency operation 1.38 0.025 1.04–1.85
Umbilical location 1.54 0.0001 1.29–1.84
Accidental exit 1.57 0.002 1.17–2.09
Specimen extraction 2.31 0.0001 1.87–2.85
Fascia closure 1.95 0.0001 1.60–2.38
Worst incision Supra-umbilical location 0.48 0.0001 0.33–0.71 5 mm TS 0.15 0.0001 0.08–0.29
Infra-umbilical location 0.32 0.0001 0.19–0.52
5 mm TS 0.07 0.0001 0.04–0.13
Umbilical location 5.63 0.0001 3.45–9.17 Accidental exit 1.65 0.056 0.98–2.77
Accidental exit 6.15 0.0001 3.32–11.4 Specimen extraction 2.17 0.005 1.27–3.72
Specimen extraction 9 56 0.0001 5.56–16.4 Fascia closure 1.99 0.011 1.17–3.40
Fascia closure 9.36 0.0001 5.76–15.21 Umbilical location 1.77 0.004 1.19–2.62
‘‘Overall nuisance’’
(VAS)
BMI 0.97 0.049 0.93–0.99 BMI 0.95 0.009 0.92–0.99
5 mm TS 0.5 0.0001 0.39–0.66 5 mm TS 0.53 0.0001 0.39–0.73
Umbilical location 1.54 0.002 1.17–2.02 Specimen extraction 1.5 0.037 1.02–2.18
Specimen extradion 1.96 0.0001 1.41 –2.73
Fascia closure 1.65 0.002 1.21 –2.25
PSAS Infra-umbilical location 0.65 0.005 0.48–0.88 5 mm TS 0 55 0.0001 0,45–0.68
5 mm TS 0.57 0.0001 0.48–0.67
cat 1 0
cat 2 1 \ 6 Accidental exit 2.12 0.0001 1.50–3.02 Accidental exit 1 95 0 001 1.29–2.94
cat 3 7 \ 20 Specimen extraction 1.62 0.001 1.23–2.12
cat 4 21 \ 60 Fascia closure 1.37 0.004 1.11 –1.70
Umbilical location 1.13 non sign
PSAS Patient Scar Assessment Score; VAS Visual Analog Scale; BMI body mass index
Table 4 Predictors of ‘‘bad TS’’ (composite endpointa)
OR p Value
Large TS 3.22 0.001
Umbilical location (vs upper or lower abdomen) 3.17 0.0001
Emergency operation 1.54 0.0001
Replaced trocar 1.79 0.022
Specimen extraction site 2.21 0.001
Fascia closure 1.71 0.006
a Defined as a trocar site where one or more of the following con-
ditions were fulfilled: pain or overall nuisance rated with a VAS
above 3 at follow-up, elected as ‘‘worst trocar,’’ rated with a PSAS
score above 6 or subject to a complication (surgical site infection
[SSI], hematoma, or hernia)
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significant correlation between oral anticoagulation and
postoperative hematoma (OR = 3.37, p = 0.001, 95 % CI
1.67–6.81). Body mass index was inversely correlated with
pain (OR = 0.96, p = 0.001, 95 % CI 0.94– 0.99) and overall
nuisance (OR = 0.95, p = 0.009, 95 % CI 0.92– 0.99).
Discussion
To our knowledge, this study is the first objective and
specific outcome analysis of laparoscopic trocars. We
assessed prospectively the morbidity of over 1,000 trocar
sites in 300 patients undergoing a multiport laparoscopic
procedure. The present analysis provides detailed and
specific quantitative assessment of the impact of individual
laparoscopic trocars on the patient’s well-being, pain, and
cosmesis, using validated scores.
Trocar size
For 5 mm TS, the overall complication rate was 0.8 %, and
relevant pain at 6 months was present in 1 % of patients; a
bad cosmetic result was reported in 4 % of 5 mm TS.
Larger trocar sites had a significantly worse outcome. This
relationship between morbidity and trocar size may be an
argument in favor of the development and use of even
smaller (3 mm) laparoscopic trocars and instruments [13].
Interestingly, one randomized study found a benefit in term
of operative length and postoperative pain with minilapa-
roscopic techniques compared to SPL [14].
Cosmesis
The cosmetic result from a patient’s point of view, using
various questionnaires and photos, after multiport laparos-
copy vs SPL has been assessed by some authors but sur-
prisingly not with validated scales or scores [12–19]. To our
knowledge, our study is the first to analyze, from a patient’s
point of view, the cosmetic results with a validated score
originally developed to assess patient satisfaction with the
scar in plastic surgery [14]. Using this score, we showed a
very low incidence of an adverse cosmetic outcome with
5 mm trocars. The only limitation of our cosmetic assess-
ment lies in the fact that our study did not include a control
group of patients without conventional TS, as for example
patients undergoing SPL or NOTES.
Morbidity
Overall trocar-related morbidity was very low. Major bleeding
at the 5 mm TS is rare [20], but spontaneously resolving minor
bleeding and bruising occurs more frequently, although very
few data are reported in the literature. We observed a rate of
trocar site hematoma of 0.7 % for 5 mm TS and 6.6 % for LTS.
Wound infections occurred only in one 5 mm TS and in 10
LTS; these results are in line with rates reported previously
between 1 % and 3 % [3, 4, 21].
Swank et al., in a recent systematic review of trocar site
hernia, reported a pooled prevalence between 0 and 5.2 % in
multiport laparoscopy. They also found a significant corre-
lation with umbilical location and trocar size [20]. Studies
comparing SPL with multiport laparoscopy report higher
rates of incisional hernia for the larger SPL port sites
(1.3–3.4 % for SPL versus 0.2–1.6 % for multiport lapa-
roscopy) [1, 3, 4, 22, 23]. In the present study, no trocar site
hernias were diagnosed, but this may be related to the short
follow-up limited to 6 months and the absence of systematic
clinical and radiological assessment in 41 % of patients, all
asymptomatic at this time-point. To date, some 10 cases of
trocar site hernia at a 5 mm TS have been reported in the
literature, but we observed none in our study. General rec-
ommendations include fascial closure of every port[10 mm
and of those\10 mm if prolonged manipulation occurs, but
the time limit is not specified [23, 24]. In our study 3 % of
5 mm trocar site fascia were closed because of enlargement
of the fascial incision during prolonged manipulation.
Localization of the trocar sites
It is a common belief among surgeons that the umbilicus is an
optimal site for trocar insertion, most likely because the scar
can be hidden in the umbilical fold. Dauser et al. performed a
preoperative survey of 150 patients planned for multiport
laparoscopy. Patients gave significantly more importance to
postoperative pain and return to normal activity than to cos-
mesis [16]. Bucher et al. performed a similar survey on 420
participants, including medical and paramedical staff,
patients and general population [17]. Only 1 % of responders
put scars as a first postoperative priority. When participants
were asked which surgical approach they would choose
between multiport laparoscopy, NOTES, and SPL, assuming
equal risk, SPL was the most common answer and the
umbilicus the preferred access [18]. Our data challenge the
idea that the umbilicus is the most ideal site for laparoscopic
access. Not only was the umbilical site independently asso-
ciated with more pain and a higher rate of SSI compared to
other locations, but surprisingly, the cosmetic outcome was
also rated worse by the patients, as reflected by the PSAS. Our
assessment might be more realistic than hypothetical preop-
erative surveys as it represents the patient’s point of view,
registered postoperatively with a validated scale. In 60 % of
our patients, the resection specimen (appendix, gallbladder)
was extracted through the umbilicus and all umbilical trocars
were LTS. One can argue that this may have contributed to a
worse outcome in terms of pain, morbidity, PSAS, and worst
incision. In fact, size of trocar and site of specimen extraction
3094 World J Surg (2014) 38:3089–3096
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were independent predictors of adverse trocar site outcome.
However, in multivariate analysis the umbilical localization
was a significant predictor of ‘‘bad TS,’’ independent of trocar
size and whether it had been used for specimen extraction or
not. Our findings should alert surgeons to reconsider the idea
of using the umbilicus as a port entry, in particular with SPL,
where a larger incision is required.
Another interesting finding in our study is that lower
abdomen TS cause significantly less pain than other locations,
independent of size and other factors. A possible explanation
may be the absence of the posterior rectus sheath in this area of
the abdomen. This may have a clinical implication in those
circumstances when the surgeon has the choice to place a
trocar below or above the level of the umbilicus.
Finally, we found that the extraction (usually accidental)
and re-insertion of trocars was independently associated
with a worse outcome. This may be explained by
enlargement of the fascial and peritoneal defect through the
re-insertion maneuvers.
Limitations
Some limitations of this study need to be adressed. As
stated in the Methods section, the follow-up was insuffi-
cient to detect all possible incisional hernias, especially in
asymptomatic patients. The study population included 300
patients, which may appear to be a relatively small sample
size, but our analysis was based on over 1,000 individual
trocar sites with a standardized assessment protocol and
use of validated scores. Outcome was assessed by an
independent investigator or a study nurse, and only in rare
cases, by the operating surgeon. Of note, the standardized
follow-up questionnaire used was designed to allow for
self-assessment by the patient for most of the outcomes,
such as pain, cosmetic result, and overall nuisance. Post-
operative analgesia was not standardized to allow a more
objective pain assessment, but this proved to be impossible
due to the different pathologies and types of laparoscopic
procedures included. Analgesia however, was based on
institutional guidelines.
Despite some limitations, the present study provides a
specific and quantitative analysis of morbidity, pain, and
cosmetic outcome related to individual trocar sites. Our
results suggest that the overall negative impact of con-
ventional trocar sites on patient well-being is very slight.
Indirectly, they suggest that the margin of improvement in
outcomes with SPL is very thin and that the threshold of
adding a 5 mm trocar to facilitate SPL should be very low.
Trocar morbidity depends on size and location of trocars,
and therefore, we suggest that, when possible, smaller
(5 mm or even 3 mm) trocars should be used, preferably
placed in the lower abdomen. The umbilicus as the pre-
ferred access point should be reconsidered, as it seems to
be more painful and was poorly evaluated from a cosmetic
point of view.
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Standardized Data Collection Questionnaire.
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Appendix 2
Questionnaire: Patient Scar Satisfaction Score (PSAS) [11].
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